Intestinal brush border transport mechanism of 5-fluorouracil in rats

被引:0
|
作者
Yuasa, H
Matsuhisa, E
Watanabe, J
机构
关键词
intestinal transport; 5-fluorouracil; pyrimidine; brush border membrane vesicle; everted sac; rat;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The intestinal transport mechanism of 5-fluorouracil (5-FU) was investigated in the intestinal everted sacs and brush border membrane vesicles (BBMVs) of rats. In the everted sacs, the initial uptake of 5-FU was apparently Na+-dependent, in terms of the inhibition of the uptake by replacing the Na+ in the medium with K+, and also concentration-dependent in the presence of Na+, with a maximum transport rate of 0.74 +/- 0.24 nmol/min/cm and a Michaelis constant of 0.025 +/- 0.018 mM. Passive transport was also significant, with a membrane permeability clearance of 5.9 +/- 0.6 mu l/min/cm. The uptake of 5-FU was inhibited by pyrimidines (uracil and thymine) and 2, 4-dinitrophenol (DNP), a metabolic inhibitor, but not by purines (adenine and guanine), pyrimidine nucleosides (thymidine and uridine), L-alanine or D-glucose. These results suggest the involvement of carrier-mediated transport specific to pyrimidines in intestinal 5-FU transport, and this appeared to satisfy the criteria of Na+-dependent secondary active transport. However, in BBMVs, 5-FU uptake was independent of Na+, minimally dependent on concentration and not inhibited by thymine, though slightly inhibited by uracil. 5-FU uptake was also independent of pH, outward HCO3- gradient and valinomycin-induced K+ diffusion potential. Thus, the carrier-mediated transport of 5-FU, or presumably pyrimidines, may require some other factors, which are yet to be identified, in addition to Na+. Alternatively, Na+ may not be prerequisite, and something else may be required in the absence of K+, as suggested from an additional result in everted sacs that the replacement of NaCl in the medium with mannitol failed to inhibit 5-FU uptake.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 50 条
  • [31] Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4
    Soares, Pedro M. G.
    Mota, Jose Mauricio S. C.
    Souza, Emmanuel P.
    Justino, Priscilla F. C.
    Franco, Alvaro X.
    Cunha, Fernando Q.
    Ribeiro, Ronaldo A.
    Souza, Marcellus H. L. P.
    CYTOKINE, 2013, 61 (01) : 46 - 49
  • [32] Effect of early preoperative 5-fluorouracil on the integrity of colonic anastomoses in rats
    Ozel, Leyla
    Ozel, M. Sefa
    Toros, Ahmet Burak
    Kara, Melih
    Ozkan, Kemal Sirri
    Tellioglu, Gurkan
    Krand, Osman
    Koyuturk, Meral
    Berber, Ibrahim
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (33) : 4156 - 4162
  • [33] Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model
    Wu, Zhenqian
    Han, Xiaodong
    Qin, Shenyin
    Zheng, Qi
    Wang, Zhigang
    Xiang, Di
    Zhang, Jing
    Lu, Huili
    Wu, Mingyuan
    Zhu, Shunying
    Yu, Yan
    Wang, Yu
    Han, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (05) : 339 - 344
  • [34] Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats
    Zhou, QY
    Chan, E
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 17 (1-2) : 73 - 80
  • [35] Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model
    Wu, Zhenqian
    Han, Xiaodong
    Qin, Shenyin
    Zheng, Qi
    Wang, Zhigang
    Xiang, Di
    Zhang, Jing
    Lu, Huili
    Wu, Mingyuan
    Zhu, Shunying
    Yu, Yan
    Wang, Yu
    Han, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (09) : 589 - 593
  • [36] Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury
    Zhang, Si
    Liu, Yanan
    Xiang, Daochun
    Yang, Jinyu
    Liu, Dong
    Ren, Xiuhua
    Zhang, Chengliang
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 910 - 916
  • [37] Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats
    Kobuchi, Shinji
    Ito, Yukako
    Hayakawa, Taro
    Nishimura, Asako
    Shibata, Nobuhito
    Takada, Kanji
    Sakaeda, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (02) : 134 - 144
  • [38] ACTION OF 5-FLUOROURACIL ON RATS WITH DMH-INDUCED COLON CANCER
    FERRE, J
    CUERVASMONS, M
    MORTE, L
    MARTINEZ, A
    CAJAL, SRY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1992, 82 (01) : 23 - 28
  • [39] Chlorination of 5-fluorouracil: Reaction mechanism and ecotoxicity assessment of chlorinated products
    Hok, Lucija
    Ulm, Lea
    Tandaric, Tana
    Krivohlavek, Adela
    Sakic, Davor
    Vrcek, Valerije
    CHEMOSPHERE, 2018, 207 : 612 - 619
  • [40] A case of 5-fluorouracil toxicity
    Fucile, C.
    Marini, V.
    Robbiano, L.
    Mattioli, F.
    Martelli, A.
    JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2011, 84 (01): : 137 - 138